Search Login Register

Cystadenocarcinoma Summary

197 relevant articles (3 outcomes, 12 trials/studies) found for this Disease

Description: A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. (Stedman, 25th ed)

Also Known As: Cystadenocarcinomas

Key Drugs and Agents for Cystadenocarcinoma

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Mucins : 1 outcome 3 studies in 28 results : IBA
  2. Antigens : 1 outcome 1 study in 12 results : IBA
  3. Hormones : 1 outcome in 3 results : IBA
  4. CA-15-3 Antigen (CA 15-3 Antigen) : 2 studies in 3 results : IBA
  5. Carcinoembryonic Antigen : 1 study in 12 results : IBA
  6. DNA (Deoxyribonucleic Acid) : 1 study in 3 results : IBA
  7. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor) : 1 study in 1 result : IBA
  8. Protein Isoforms (Isoforms) : 1 study in 1 result : IBA
  9. Neopterin : 1 study in 1 result : IBA
  10. Transforming Growth Factor beta (TGF-beta) : 1 study in 1 result : IBA
Show All >>

Diseases Related to Cystadenocarcinoma

  1. Neoplasms (Cancer)
  2. Cholangiocarcinoma
  3. Adenocarcinoma
  4. Cysts
  5. Hepatocellular Carcinoma (Hepatoma)
Show All >>

Key Therapies for Cystadenocarcinoma

Efficacy Chart >>
  1. Hepatectomy : 2 studies in 8 results
  2. Pancreatectomy : 13 results
  3. Drug Therapy (Chemotherapy) : 12 results
  4. Pancreaticoduodenectomy : 8 results
  5. Laparotomy : 5 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.